Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02312960 · ClinicalTrials.gov registry record · Phase 4
Radium-223 Dichloride Long-term Follow-up Program
A Phase 4 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 4
- Development phase
- 255
- Enrollment target
NCT02312960 is a Phase 4 study that has completed, run by Bayer. The registered enrollment target is 255 participants.
The verdict
NCT02312960, a Phase 4 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 255 participants
- Enrollment target
Study Summary
Patients will be followed up in this study after prior treatment with BAY88-8223 / Radium-223 dichloride / Xofigo.
Interventions
- OTHER Data Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2014-12-18 |
| Est. Completion | 2024-01-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02312960
The ClinicalTrials.gov registry entry for NCT02312960 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Data Collection is the first listed.
NCT02312960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02312960 about?
NCT02312960 is a clinical study titled "Radium-223 Dichloride Long-term Follow-up Program". Patients will be followed up in this study after prior treatment with BAY88-8223 / Radium-223 dichloride / Xofigo.
What is the current status of trial NCT02312960?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 255 participants. The study started on 2014-12-18. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT02312960?
The interventions under investigation include: Data Collection (OTHER).
Who is sponsoring clinical trial NCT02312960?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.